Photo shows an announcement released by China Meheco, Dec. 12, 2022. (Screenshot Photo)
(ECNS) -- China Meheco said on Wednesday it signed an agreement with Pfizer Inc to import and distribute its oral COVID-19 treatment Paxlovid in the Chinese mainland.
The agreement is valid between Dec. 14 and Nov. 30, 2023, China Meheco said in its announcement.
京公網安備 11010202009201號